Revance Therapeutics (RVNC)
(Delayed Data from NSDQ)
$2.68 USD
+0.26 (10.74%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $2.72 +0.04 (1.49%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.48 | 0.00% |
Earnings Summary
For their last quarter, Revance Therapeutics (RVNC) reported earnings of -$0.54 per share, beating the Zacks Consensus Estimate of $-0.66 per share. This reflects a positive earnings surprise of 18.18%. Look out for RVNC's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.48 per share, reflecting a year-over-year increase of 40%.
Earnings History
Price & Consensus
Zacks News for RVNC
Revance Therapeutics, Inc. (RVNC) Reports Q1 Loss, Lags Revenue Estimates
RVNC: What are Zacks experts saying now?
Zacks Private Portfolio Services